UBS Group AG - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 48 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$210,314
+1.5%
13,311
-2.8%
0.00%
Q2 2023$207,236
+880.9%
13,688
+839.5%
0.00%
Q1 2023$21,127
+24.3%
1,457
+15.9%
0.00%
Q4 2022$16,995
+112.4%
1,257
+110.6%
0.00%
Q2 2022$8,000
-38.5%
597
-58.7%
0.00%
Q1 2022$13,000
-72.9%
1,447
-48.6%
0.00%
Q4 2021$48,0002,8140.00%
Other shareholders

There were no reported owners of ENTRADA THERAPEUTICS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of ENTRADA THERAPEUTICS INC shareholders